Flow Cytometric Immune Profiling Enables Early Detection of Rejection in Islet Xenotransplantation
Xenotransplantation · 2026-09 · 33 (5)
DOI: 10.1111/xen.70170 ↗Kurz gefasst
Fachartikel in der Zeitschrift Xenotransplantation, online erschienen am 23.09.2026. Verfasst von Huu Thanh Le und 10 weiteren Autor:innen. Beteiligte Einrichtung: Translational Transplantation Therapies, Westmead Institute for Medical Research, Westmead, New South Wales, Australia. Hauptthemen laut MEDLINE: Islets of Langerhans Transplantation, Graft Rejection, Transplantation, Heterologous, Flow Cytometry. Die Arbeit nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NH&MRC, Breakthrough T1D.
Abstract (Originalsprache)
Background
Islet xenotransplantation is a strategy for treatment of Type 1 Diabetes, but immune‐mediated rejection limits graft survival. This study investigated a strategy with flow cytometry–based immune monitoring to evaluate immunosuppressive therapy and provide indicators of graft rejection.
Methods
Porcine neonatal islet cell clusters (NICC) from GTKO‐hCD55‐hCD59 transgenic pigs were transplanted into streptozotocin‐induced diabetic baboons ( n = 10). Recipients received anti‐CD2 induction with anti‐CD154, Belatacept, and full‐dose ( n = 7) or reduced/no dose Tacrolimus ( n = 3). Leukocyte subsets and activation status were monitored using multiplex flow cytometry. Graft function was assessed by blood glucose measurements, porcine C‐peptide ELISA, and histological analysis.
Results
Porcine C‐peptide was detected in all recipients. Seven animals receiving full‐dose Tacrolimus maintained NICC function for up to 675 days, whereas three experienced acute rejection within two months. Flow cytometry generated absolute leukocyte counts equivalent to standard full blood counts (Deming regression slope 0.91–1.03, p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Translational Transplantation Therapies, Westmead Institute for Medical Research, Westmead, New South Wales, Australia.
- Immunology Research Centre, St. Vincent's Hospital, Melbourne, Victoria, Australia.
- Department of Medicine, University of Melbourne, Melbourne, Victoria, Australia.
- School of Biomedicine, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, South Australia, Australia.
- Department of Surgery, School of Medical Sciences, Westmead Hospital, University of Sydney, Westmead, New South Wales, Australia.
ORCID-Profile: Huu Thanh Le, Erin Fuller, Evelyn J Salvaris, Yivee Chew, Francesco Ierino, Mark B Nottle, Peter J Cowan, Wayne J Hawthorne
Förderung
- NH&MRC
- Breakthrough T1D
Zitieren
APA
Le, H. T., Fuller, E., Joo, L., Salvaris, E. J., Thomas, A., Chew, Y., Hu, M., Ierino, F., Nottle, M. B., Cowan, P. J., & Hawthorne, W. J. (2026). Flow Cytometric Immune Profiling Enables Early Detection of Rejection in Islet Xenotransplantation. Xenotransplantation, 33(5). https://doi.org/10.1111/xen.70170
Vancouver
Le HT, Fuller E, Joo L, Salvaris EJ, Thomas A, Chew Y, et al. Flow Cytometric Immune Profiling Enables Early Detection of Rejection in Islet Xenotransplantation. Xenotransplantation. 2026;33(5). doi:10.1111/xen.70170
BibTeX
@article{Le2026,
author = {Le, Huu Thanh and Fuller, Erin and Joo, Lauen and Salvaris, Evelyn J and Thomas, Adwin and Chew, Yivee and Hu, Min and Ierino, Francesco and Nottle, Mark B and Cowan, Peter J and Hawthorne, Wayne J},
title = {Flow Cytometric Immune Profiling Enables Early Detection of Rejection in Islet Xenotransplantation},
journal = {Xenotransplantation},
year = {2026},
volume = {33},
number = {5},
doi = {10.1111/xen.70170}
}
EUVIMED